ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Bartley P. Griffith
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mattsson, P.
Right arrow Articles by Griffith, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mattsson, P.
Right arrow Articles by Griffith, B. P.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;62:207-212
© 1996 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Effect of Aminoguanidine and Cyclosporine on Lung Allograft Rejection

Pella Mattsson, MD, Adriana Zeevi, PhD, Jane Cai, Samuel A. Yousem, MD, Rosemary Hoffman, PhD, Michael Nalesnik, MD, Gilbert J. Burckart, PharmD, David Geller, MD, Bartley P. Griffith, MD

Divisions of Cardiothoracic Surgery, Immunopathology, Pathology, and Pharmacology, and Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Background. Aminoguanidine, a nitric oxide synthase inhibitor, has been shown to reduce the inflammatory allogeneic response. Here we used it in combination with cyclosporine to evaluate its effect on a clinically relevant immunosuppressive protocol.

Methods. Orthotopic left lung transplantation was performed in 120 rats, of which 24 were syngeneic Lewis to Lewis controls, and allogeneic transplantations were performed across major histoincompatibility barriers (ACI to Lewis). We studied synchronous histologic changes accompanying cytokines and nitric oxide synthase messenger RNA by reverse transcriptase polymerase chain reaction in the grafted lungs. Nitrate/nitrite, oxidized degradation products of nitric oxide, were measured in the whole blood, as were concentrations of cyclosporine. Lung tissue was immunohistochemically stained for nitric oxide synthase protein. Rats receiving allografts were either untreated (24) or received low-dose cyclosporine (232 ± 105 ng/mL blood by high-performance liquid chromatography), high-dose cyclosporine (2,046 ± 664 ng/mL), aminoguanidine alone (800 mg•kg-1•day-1 intraperitoneally), or aminoguanidine plus low-dose cyclosporine.

Results. The results suggest that aminoguanidine combined with low doses of cyclosporine can reduce the allogeneic response across major histoincompatibilities in rodent lung transplantation. Its biologic effect may not exclusively depend on the inhibition of nitric oxide synthase and may, by other means, reduce proinflammatory cytokines.

Conclusions. Aminoguanidine may be an effective adjuvant to conventional immunosuppression.


Related Article

Discussion
Ann. Thorac. Surg. 1996 62: 212. [Extract] [Full Text]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
D. Hongo, J. S. Bryson, A. M. Kaplan, and D. A. Cohen
Endogenous Nitric Oxide Protects against T Cell-Dependent Lethality during Graft-versus-Host Disease and Idiopathic Pneumonia Syndrome
J. Immunol., August 1, 2004; 173(3): 1744 - 1756.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. M. Wildhirt, S. Weismueller, C. Schulze, N. Conrad, A. Kornberg, and B. Reichart
Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury
Cardiovasc Res, August 15, 1999; 43(3): 698 - 711.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. E. SILKOFF, M. CARAMORI, L. TREMBLAY, P. MCCLEAN, C. CHAPARRO, S. KESTEN, M. HUTCHEON, A. S. SLUTSKY, N. ZAMEL, and S. KESHAVJEE
Exhaled Nitric Oxide in Human Lung Transplantation . A Noninvasive Marker of Acute Rejection
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1822 - 1828.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. N. Mitruka, S. M. Pham, A. Zeevi, S. Li, J. Cai, G. J. Burckart, S. A. Yousem, R. J. Keenan, and B. P. Griffith
Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation
J. Thorac. Cardiovasc. Surg., January 1, 1998; 115(1): 28 - 37.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.